Uttarakhand Suspends Permissions Of 14 Products Of Ramdev’s Pharma Firms

Haridwar: An Indian state regulator has suspended manufacturing licences of 14 products made by pharmaceutical companies of the country’s most popular yoga guru for repeatedly publishing misleading advertisements about their efficacy, a government order showed.

The order is the latest setback for Baba Ramdev whose TV shows, yoga cures and traditional medicine offerings for diseases have made him popular in India and other nations.

The Supreme Court of India has in recent weeks repeatedly criticised Ramdev for not complying with its directives in an ongoing lawsuit to stop misleading advertisements of some of his traditional ayurvedic medicines.

The manufacturing permits of Ramdev’s companies were suspended in an April 15 order by the drug regulator of traditional medicines in northern Uttarakhand state. Reuters is the first to report the order which is not public.

The list of 14 products whose licences were suspended included Ramdev’s traditional medicines for asthma, bronchitis and diabetes.

The manufacturing permits are “suspended with immediate effect”, Mithilesh Kumar of the state regulator wrote in his order.

A spokesperson for Ramdev said he did not have any immediate comment on the matter.

The list of 14 products whose licences were suspended included Ramdev’s traditional medicines for asthma, bronchitis and diabetes.

The manufacturing permits are “suspended with immediate effect”, Mithilesh Kumar of the state regulator wrote in his order.

A spokesperson for Ramdev said he did not have any immediate comment on the matter.

Related Posts

  • Pharma
  • September 7, 2024
  • 123 views
Haryana-Based Drug Dist. Arrested For Supplying Prescription Drugs To Coimbatore Peddlers

Coimbatore: A special team of the Coimbatore City Police has arrested a Haryana-based drug distributor on charges of supplying prescription drugs to peddlers in Coimbatore. The police said that Sachin Garg,…

  • Pharma
  • September 7, 2024
  • 100 views
Inappropriate Use Of ‘Sulopenem’ Could Cause Antimicrobial Resistance (AMR)

Maryland: Five months after signing off on Utility Therapeutics’ Pivya as the first new treatment for uncomplicated urinary tract infections (uUTIs) in more than two decades, the FDA is weighing the pros and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Haryana-Based Drug Dist. Arrested For Supplying Prescription Drugs To Coimbatore Peddlers

Haryana-Based Drug Dist. Arrested For Supplying Prescription Drugs To Coimbatore Peddlers

People with Spinal Injuries are left to fend for themselves in India

People with Spinal Injuries are left to fend for themselves in India

Inappropriate Use Of ‘Sulopenem’ Could Cause Antimicrobial Resistance (AMR)

Inappropriate Use Of ‘Sulopenem’ Could Cause Antimicrobial Resistance (AMR)

Medical Shop Owner Faces Charges For Drug Money Laundering In Punjab

Medical Shop Owner Faces Charges For Drug Money Laundering In Punjab

Narayana Health is poised to transform Nurses Skills to enhance Patient Outcomes

Narayana Health is poised to transform Nurses Skills to enhance Patient Outcomes

DCGI Seeks Explanation From Entod Pharma Claiming Eye Drops Can Cure Eyesight

DCGI Seeks Explanation From Entod Pharma Claiming Eye Drops Can Cure Eyesight